Kim SY, Jeong EH, Lee TG, Kim HR, et al. The Combination of Trametinib, a MEK Inhibitor, and Temsirolimus, an mTOR Inhibitor, Radiosensitizes Lung Cancer Cells. Anticancer Res 2021;41:2885-2894.
PMID: 34083279